Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016040
Filing Date
2019-05-06
Accepted
2019-05-06 17:30:30
Documents
82
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-10q_20190331.htm 10-Q 1825873
2 EX-4.7 xoma-ex47_58.htm EX-4.7 100820
3 EX-10.3 xoma-ex103_57.htm EX-10.3 139619
4 EX-31.1 xoma-ex311_8.htm EX-31.1 15916
5 EX-31.2 xoma-ex312_7.htm EX-31.2 15921
6 EX-32.1 xoma-ex321_9.htm EX-32.1 7228
  Complete submission text file 0001564590-19-016040.txt   8369767

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT xoma-20190331.xml EX-101.INS 1541066
8 XBRL TAXONOMY EXTENSION SCHEMA xoma-20190331.xsd EX-101.SCH 102447
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xoma-20190331_cal.xml EX-101.CAL 54448
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20190331_def.xml EX-101.DEF 334201
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20190331_lab.xml EX-101.LAB 667170
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20190331_pre.xml EX-101.PRE 508851
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14710 | Film No.: 19800497
SIC: 2834 Pharmaceutical Preparations